Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$940,083
-$166,353 QoQ
Shares Held
39,040
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,361
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COURIER CAPITAL LLC holds $42,194,870 across 11 Drug Manufacturers - General names. PFE ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,486 | $16,377,509 | |
| 2 | MRK |
Merck & Co., Inc.
|
53,603 | $6,887,985 | |
| 3 | LLY |
ELI LILLY & Co
|
4,669 | $5,600,139 | |
| 4 | AMGN |
Amgen Inc
|
12,257 | $4,438,504 | |
| 5 | ABBV |
AbbVie Inc.
|
15,875 | $3,994,785 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,523 | $2,046,835 | |
| 7 | AZN |
Astrazeneca PLC
|
5,104 | $967,820 | |
| 8 | PFE |
Pfizer Inc
This page
|
39,040 | $940,083 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $940,083 | 39,040 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,106,436 | 39,403 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,008,699 | 40,510 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,093,066 | 42,899 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,048,258 | 43,245 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,343,856 | 53,033 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,362,766 | 51,367 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,725,344 | 59,618 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,703,477 | 60,882 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,775,278 | 63,974 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,515,949 | 122,124 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $4,191,527 | 126,365 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $4,691,005 | 127,890 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $4,812,319 | 117,949 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $6,310,206 | 123,150 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $5,502,732 | 125,748 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $6,634,020 | 126,531 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,459,601 | 124,775 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,659,788 | 129,717 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $5,779,210 | 134,369 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $5,296,194 | 135,245 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $5,052,019 | 139,443 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $4,651,348 | 126,361 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,591,202 | 125,101 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $4,187,173 | 128,048 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $3,986,546 | 122,137 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||